AK120 or placebo- Part 1- Cohort 1
AK120-101
Phase 1 small_molecule completed
Quick answer
AK120 or placebo- Part 1- Cohort 1 for Atopic Dermatitis is a Phase 1 program (small_molecule) at Akeso with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Akeso
- Indication
- Atopic Dermatitis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed